The ongoing COVID-19 pandemic is arguably one of the most challenging health crises in
modern times. The development of effective strategies to control the spread of SARS-CoV-2 …

Abstract The coronavirus disease (COVID‐19), which the World Health Organization
classified as the Sixth Public Health Emergency Of International Concern (PHEIC) on …

We have developed Convacell®—a COVID-19 vaccine based on the recombinant
nucleocapsid (N) protein of SARS-CoV-2. This paper details Convacell's® combined phase …

More than 700 million confirmed cases of Coronavirus Disease-2019 (COVID-19) have
been reported globally, and 10–60% of patients are expected to exhibit “post-COVID-19 …

Several vaccine programs were introduced during the COVID-19 pandemic, which included
inactivated virus, DNA viral vectors and mRNA vaccines. Booster programs are …

Since the advent of COVID-19 vaccine, the long-term monitoring and evaluation of vaccine
effectiveness worldwide has never stopped. Real-world research of the mainstream …

Аннотация Состояние мирового рынка биофармпрепаратов в настоящее время
приобретает особое значение не только как важнейшая экономическая …

Introduction: Despite the efficacy of the COVID-19, the search for improvements in the
management of severe/critical cases continues to be important. The aim is to demonstrate …

There has been much interest in accurate cryptocurrency price forecast models by investors
and researchers. Deep Learning models are prominent machine learning techniques that …

We have developed a Convacell®, a COVID-19 vaccine based on the conservative viral
nucleocapsid (N) protein. The N protein is evolutionary conservative and is abundantly …